Palmitic acid

Partly covered — depends on the product. 'ex' entry: only the relevant commodity part of this heading is in scope. Product-level review is required.

Code 29157015Verdict Partly in scopeCommodity Oil PalmAnnex I 291570CN 2026

Tool resultPartly in scope

Next action

Request supplier evidence

'ex' entry: only the relevant commodity part of this heading is in scope. Product-level review is required.

Open reference record

Decision basis

What the checker used.

Product namePalmitic acid

Code pathORGANIC CHEMICALS

Annex I matchPalmitic acid, stearic acid, their salts and esters, synthesized using oil palm (not including products used in the manufacturing of medicinal products for human or veterinary use)

BasisRegulation (EU) 2023/1115 Annex I and CN 2026 index

Operator workflow

Use the result, then move on.

01Confirm the product description with the importer or supplier.
02Ask for country of production and plot geolocation before any filing workflow.
03Collect legality and deforestation-free support documents for the shipment file.

What the code cannot tell you

Product facts can still change the answer.

Is the product made entirely from material that has completed its lifecycle and would otherwise be discarded as waste?If yes: out of scope

By-products of a manufacturing process do not benefit from this exception — if the process used material that was not waste, the product stays in scope.

Annex I introductory paragraph; Directive 2008/98/EC Art. 3(1)

Is it a sample of negligible value and quantity used only to solicit orders, or a product sent for examination or testing that is used up, destroyed or returned?If yes: out of scopeDelegated Regulation (EU) 2026/2102, Annex (5), table note to 'Relevant products'

Was it produced without oil palm (Elaeis spp.) — from other vegetable oils, animal fats or petrochemical feedstock?If yes: out of scope

Babassu oil and oils of other palm species are outside the scope as well.

Delegated Regulation (EU) 2026/2102, Annex (2) and (6)(f)–(s)

Is it used in manufacturing medicinal products for human or veterinary use (Directive 2001/83/EC, Regulation (EC) No 726/2004 or Regulation (EU) 2019/6)?If yes: out of scopeDelegated Regulation (EU) 2026/2102, Annex (6)(g)–(s)

What you have to collect

Supplier evidence starts after scope.

'ex' entry: only the relevant commodity part of this heading is in scope. Product-level review is required.

Product description
Quantity
Country of production
Geolocation
Supplier information
Legality evidence
Deforestation-free evidence